An improved respiratory syncytial virus neutralization assay based on the detection of green fluorescent protein expression and automated plaque counting

Virology Journal

Volumn 9, Issue , 2012, Pages

  Van Remmerden, Yvonne ^a   Xu, Fang ^a   Van Eldik, Mandy ^a   Heldens, Jacco G M ^b,c   Huisman, Willem ^b,c   Widjojoatmodjo, Myra N ^a,d  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b Nobilon International BV   (Netherlands)

^c INTERVET INTERNATIONAL BV   (Netherlands)

^d CRUCELL HOLLAND BV   (Netherlands)

Author keywords

EGFP; RSV; Virus neutralization

Indexed keywords

COMPLEMENT; ENHANCED GREEN FLUORESCENT PROTEIN; NEUTRALIZING ANTIBODY;

ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIROGENESIS; VIRUS GENE; VIRUS NEUTRALIZATION; VIRUS PLAQUE; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL LINE; CERCOPITHECUS AETHIOPS; GREEN FLUORESCENT PROTEINS; HEP G2 CELLS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; VERO CELLS; VIRAL PLAQUE ASSAY;

ANIMALIA; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 84868231329     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-253     Document Type: Article

References (21)

1. Respiratory syncytial virus infection in elderly and high-risk adults. Falsey AR, Exp Lung Res 2005 31 Suppl 1 77 16395866 (Pubitemid 41361789)
2. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL, J Pediatr 1981 98 708 715 10.1016/S0022-3476(81)80829-3 7229749 (Pubitemid 11070320)
3. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Lancet 2010 375 1545 1555 10.1016/S0140-6736(10)60206-1 20399493
4. Influenza and respiratory syncytial virus in the elderly. Elliot AJ, Fleming DM, Expert Rev Vaccines 2008 7 249 258 10.1586/14760584.7.2.249 18324893 (Pubitemid 351357959)
5. Challenges in developing a pediatric RSV vaccine. Schickli JH, Dubovsky F, Tang RS, Hum Vaccin 2009 5 582 591 19556888
6. Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay. Anderson LJ, Hierholzer JC, Bingham PG, Stone YO, J Clin Microbiol 1985 22 1050 1052 4066916 (Pubitemid 16222738)
7. Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay. Siber GR, Leszcynski J, Pena-Cruz V, Ferren-Gardner C, Anderson R, Hemming VG, et al. J Infect Dis 1992 165 456 463 10.1093/infdis/165.3.456 1538152
8. Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: results from the palivizumab outcomes registry. Parnes C, Guillermin J, Habersang R, Nicholes P, Chawla V, Kelly T, et al. Pediatr Pulmonol 2003 35 484 489 12746948
9. A simplified plaque assay for respiratory syncytial virus-direct visualization of plaques without immunostaining. McKimm-Breschkin JL, J Virol Methods 2004 120 113 117 10.1016/j.jviromet.2004.02.020 15234816 (Pubitemid 38968662)
10. Development of an improved microneutralization assay for respiratory syncytial virus by automated plaque counting using imaging analysis. Zielinska E, Liu D, Wu HY, Quiroz J, Rappaport R, Yang DP, Virol J 2005 2 84 10.1186/1743-422X-2-84 16281972 (Pubitemid 41772396)
11. Rapid human metapneumovirus microneutralization assay based on green fluorescent protein expression. Biacchesi S, Skiadopoulos MH, Yang L, Murphy BR, Collins PL, Buchholz UJ, J Virol Methods 2005 128 192 197 10.1016/j.jviromet. 2005.05.005 15955576 (Pubitemid 40980227)
12. An improved plaque reduction virus neutralization assay for human metapneumovirus. de Graaf M, Herfst S, Schrauwen EJ, van den Hoogen BG, Osterhaus AD, Fouchier RA, J Virol Methods 2007 143 169 174 10.1016/j.jviromet. 2007.03.005 17420056 (Pubitemid 46963389)
13. Neutralization assay using a modified vaccinia virus ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus. Cosma A, Buhler S, Nagaraj R, Staib C, Hammarin AL, Wahren B, et al. Clin Diagn Lab Immunol 2004 11 406 410 15013995 (Pubitemid 38380825)
14. Role of complement in neutralization of respiratory syncytial virus. Yoder SM, Zhu Y, Ikizler MR, Wright PF, J Med Virol 2004 72 688 694 10.1002/jmv.20046 14981775 (Pubitemid 38296084)
15. Preparation of a respiratory syncytial virus human reference serum for use in the quantitation of neutralization antibody. Yang DP, Zielinska E, Quiroz J, Madore D, Rappaport R, Biologicals 2007 35 183 187 10.1016/j.biologicals. 2006.09.004 17241789 (Pubitemid 46891850)
16. A highly attenuated recombinant human respiratory syncytial virus lacking the G protein induces long-lasting protection in cotton rats. Widjojoatmodjo MN, Boes J, van Bers M, van Remmerden Y, Roholl PJ, Luytjes W, Virol J 2010 7 114 10.1186/1743-422X-7-114 20525213
17. Diverse gene junctions of respiratory syncytial virus modulate the efficiency of transcription termination and respond differently to M2- mediated antitermination. Hardy RW, Harmon SB, Wertz GW, J Virol 1999 73 170 176 9847319 (Pubitemid 28565358)
18. Effects of altering the transcription termination signals of respiratory syncytial virus on viral gene expression and growth in vitro and in vivo. Tran KC, Collins PL, Teng MN, J Virol 2004 78 692 699 10.1128/JVI.78.2.692-699.2004 14694100 (Pubitemid 38067590)
19. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. Hallak LK, Spillmann D, Collins PL, Peeples ME, J Virol 2000 74 10508 10513 10.1128/JVI.74.22.10508-10513.2000 11044095
20. A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate. Chen M, Chang JS, Nason M, Rangel D, Gall JG, Graham BS, et al. J Immunol Methods 2010 362 180 184 10.1016/j.jim.2010.08.005 20727896
21. Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein. Walsh EE, Hruska J, J Virol 1983 47 171 177 6345804 (Pubitemid 13107071)